EP

Epi Biotech Co., Ltd.

Develops hair loss therapies and provides preclinical CRO services.

446440 | KO

Overview

Corporate Details

ISIN(s):
KR7446440000
LEI:
Country:
South Korea
Address:
인천광역시 연수구 송도과학로 32 엠동 1903호(송도동, 송도테크노파크아이티센터), 인천광역시

Description

Epi Biotech Co., Ltd. is a biopharmaceutical company focused on the research and development of treatments for hair loss. The company utilizes a large genomic database and AI-driven drug discovery platforms to advance its pipeline, which includes cell and antibody therapeutics for hair restoration. In addition to its primary focus, Epi Biotech conducts R&D in skin regeneration. The company also provides specialized preclinical Contract Research Organization (CRO) services, offering expertise in hair loss research and efficacy evaluation.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-31 00:00
임시주주총회결과
Korean 8.2 KB
2025-07-31 00:00
주식매수선택권부여에관한신고
Korean 20.6 KB
2025-07-16 00:00
[기재정정]주주총회소집결의
Korean 12.9 KB
2025-07-16 00:00
주주총회소집공고
Korean 71.6 KB
2025-06-24 00:00
주주총회소집결의
Korean 8.1 KB
2025-06-24 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.3 KB
2025-05-12 00:00
주식등의대량보유상황보고서(약식)
Korean 168.9 KB
2025-04-24 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-04-16 00:00
주요사항보고서(유상증자결정)
Korean 51.4 KB
2025-03-26 00:00
정기주주총회결과
Korean 17.2 KB
2025-03-26 00:00
주식등의대량보유상황보고서(일반)
Korean 91.4 KB
2025-03-19 00:00
증권발행결과(자율공시)
Korean 5.1 KB
2025-03-19 00:00
증권발행결과(자율공시) (제3자배정 유상증자)
Korean 5.1 KB
2025-03-18 00:00
감사보고서제출
Korean 9.8 KB
2025-03-18 00:00
사업보고서 (2024.12)
Korean 748.3 KB

Automate Your Workflow. Get a real-time feed of all Epi Biotech Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Epi Biotech Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Epi Biotech Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

LYSOGENE Logo
A former clinical-stage biotech that developed gene therapies for rare CNS diseases.
France
LYS
MaaT Pharma Logo
A clinical-stage biotech developing microbiome-based therapeutics for oncology.
France
MAAT
Matinas BioPharma Holdings, Inc. Logo
Biopharma firm developing therapeutics using its Lipid Nanocrystal (LNC) platform.
United States of America
MTNB
Matricelf Ltd. Logo
Develops autologous, patient-specific tissue implants for regenerative medicine.
Israel
MTLF
MAXCYTE, INC. Logo
A cell-engineering company with a platform for developing cell-based therapeutics.
United States of America
MXCT
Medicofarma Biotech Spolka Akcyjna Logo
R&D company developing innovative medicines, medical devices, and biotech products.
Poland
MDB
Medigene AG Logo
Develops TCR-guided immunotherapies for cancer; currently in insolvency proceedings.
Germany
MDG1
Medizen Humancare Inc Co., Ltd Logo
A research company specializing in genomic analysis for personalized healthcare.
South Korea
236340
Medpace Holdings, Inc. Logo
A global CRO providing Phase I-IV clinical development for biotech and pharma industries.
United States of America
MEDP
A clinical-stage biotech developing nanomedicines for oncology and diagnostics.
Malaysia
N/A

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.